These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Systemic lupus erythematosus. Clinical, biological and immunological studies. (Report on 30 cases). II]. Nouspikel P Praxis; 1968 Jun; 57(24):875-90. PubMed ID: 4888332 [No Abstract] [Full Text] [Related]
43. Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML. Huber C; Pfister R; Stingl G Clin Exp Immunol; 1982 Dec; 50(3):525-33. PubMed ID: 6219834 [TBL] [Abstract][Full Text] [Related]
44. [The role of T-lymphocyte and killer-cell defects in the pathogenesis of systemic lupus erythematodes]. Wollina U Dermatol Monatsschr; 1983; 169(12):749-61. PubMed ID: 6230266 [No Abstract] [Full Text] [Related]
45. Idiotypes in systemic lupus erythematosus. Clues for understanding etiology and pathogenicity. Shefner R; Manheimer-Lory A; Davidson A; Paul E; Aranow C; Katz J; Diamond B Chem Immunol; 1990; 48():82-108. PubMed ID: 2294929 [No Abstract] [Full Text] [Related]
46. Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice. Shirai T; Hirose S; Sekigawa I; Okada T; Sato H J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():11-20. PubMed ID: 3497267 [TBL] [Abstract][Full Text] [Related]
48. An update on pathogenesis of systemic lupus erythematosus. Ahmadpoor P; Dalili N; Rostami M Iran J Kidney Dis; 2014 May; 8(3):171-84. PubMed ID: 24878938 [TBL] [Abstract][Full Text] [Related]
49. [Studies on the lysis of lymphocytes of patients with systemic lupus erythematosus--with relation to lymphocyte subpopulation (author's transl)]. Tanaka Z Ryumachi; 1977 Jul; 17(4):388-95. PubMed ID: 302991 [No Abstract] [Full Text] [Related]